Aberrant development of neuromuscular junctions in glycosylation-defective Largemyd mice

Neuromuscular Disorders

Volumn 19, Issue 5, 2009, Pages 366-378

  Herbst, Ruth ^a   Iskratsch, Thomas ^b   Unger, Ewald ^b   Bittner, Reginald E ^b  

^a Medical University of Vienna   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Dystroglycan; Glycosylation; Neuromuscular junction; Skeletal muscle

Indexed keywords

AGRIN; ALPHA BUNGAROTOXIN; CHOLINERGIC RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MATURATION; CONTROLLED STUDY; GLYCOSYLATION; MOUSE; MYOTUBE; NERVE ENDING; NERVE SPROUTING; NEUROMUSCULAR SYNAPSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

AGRIN; ANIMALS; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MICE, MUTANT STRAINS; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MUTATION; N-ACETYLGLUCOSAMINYLTRANSFERASES; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR JUNCTION DISEASES; PRESYNAPTIC TERMINALS; RECEPTORS, NICOTINIC; SYNAPTIC MEMBRANES;

EID: 67349118126     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2009.02.011     Document Type: Article

References (70)

1. Martin P.T., and Sanes J.R. Role for a synapse-specific carbohydrate in agrin-induced clustering of acetylcholine receptors. Neuron 14 (1995) 743-754
2. Martin P.T., Scott L.J., Porter B.E., and Sanes J.R. Distinct structures and functions of related pre- and postsynaptic carbohydrates at the mammalian neuromuscular junction. Mol Cell Neurosci 13 (1999) 105-118
3. Martin P.T. Glycobiology of the synapse. Glycobiology 12 (2002) 1R-7R
4. Gehle V.M., Walcott E.C., Nishizaki T., and Sumikawa K. N-glycosylation at the conserved sites ensures the expression of properly folded functional ACh receptors. Brain Res Mol Brain Res 45 (1997) 219-229
5. Blount P., and Merlie J.P. Mutational analysis of muscle nicotinic acetylcholine receptor subunit assembly. J Cell Biol 111 (1990) 2613-2622
6. Merlie J.P., Sebbane R., Tzartos S., and Lindstrom J. Inhibition of glycosylation with tunicamycin blocks assembly of newly synthesized acetylcholine receptor subunits in muscle cells. J Biol Chem 257 (1982) 2694-2701
7. Prives J., and Bar-Sagi D. Effect of tunicamycin, an inhibitor of protein glycosylation, on the biological properties of acetylcholine receptor in cultured muscle cells. J Biol Chem 258 (1983) 1775-1780
8. Tsen G., Halfter W., Kroger S., and Cole G.J. Agrin is a heparan sulfate proteoglycan. J Biol Chem 270 (1995) 3392-3399
9. Winzen U., Cole G.J., and Halfter W. Agrin is a chimeric proteoglycan with the attachment sites for heparan sulfate/chondroitin sulfate located in two multiple serine-glycine clusters. J Biol Chem 278 (2003) 30106-30114
10. Burgess R.W., Nguyen Q.T., Son Y.J., Lichtman J.W., and Sanes J.R. Alternatively spliced isoforms of nerve- and muscle-derived agrin: their roles at the neuromuscular junction. Neuron 23 (1999) 33-44
11. Watty A., and Burden S.J. MuSK glycosylation restrains MuSK activation and acetylcholine receptor clustering. J Biol Chem 277 (2002) 50457-50462
12. Cohn R.D., and Campbell K.P. Molecular basis of muscular dystrophies. Muscle Nerve 23 (2000) 1456-1471
13. Adams M.E., Kramarcy N., Fukuda T., Engel A.G., Sealock R., and Froehner S.C. Structural abnormalities at neuromuscular synapses lacking multiple syntrophin isoforms. J Neurosci 24 (2004) 10302-10309
14. Deconinck A.E., Potter A.C., Tinsley J.M., Wood S.J., Vater R., Young C., et al. Postsynaptic abnormalities at the neuromuscular junctions of utrophin-deficient mice. J Cell Biol 136 (1997) 883-894
15. Patton B.L., Cunningham J.M., Thyboll J., Kortesmaa J., Westerblad H., Edstrom L., et al. Properly formed but improperly localized synaptic specializations in the absence of laminin α4. Nat Neurosci 4 (2001) 597-604
16. Williamson R.A., Henry M.D., Daniels K.J., Hrstka R.F., Lee J.C., Sunada Y., et al. Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice. Hum Mol Genet 6 (1997) 831-841
17. Cote P.D., Moukhles H., Lindenbaum M., and Carbonetto S. Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses. Nat Genet 23 (1999) 338-342
18. Jacobson C., Cote P.D., Rossi S.G., Rotundo R.L., and Carbonetto S. The dystroglycan complex is necessary for stabilization of acetylcholine receptor clusters at neuromuscular junctions and formation of the synaptic basement membrane. J Cell Biol 152 (2001) 435-450
19. Grewal P.K., Holzfeind P.J., Bittner R.E., and Hewitt J.E. Mutant glycosyltransferase and altered glycosylation of α-dystroglycan in the myodystrophy mouse. Nat Genet 28 (2001) 151-154
20. Holzfeind P.J., Grewal P.K., Reitsamer H.A., Kechvar J., Lassmann H., Hoeger H., et al. Skeletal, cardiac and tongue muscle pathology, defective retinal transmission, and neuronal migration defects in the Large(myd) mouse defines a natural model for glycosylation-deficient muscle-eye-brain disorders. Hum Mol Genet 11 (2002) 2673-2687
21. Michele D.E., Barresi R., Kanagawa M., Saito F., Cohn R.D., Satz J.S., et al. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 418 (2002) 417-422
22. Peyrard M., Seroussi E., Sandberg-Nordqvist A.C., Xie Y.G., Han F.Y., Fransson I., Collins J., Dunham I., Kost-Alimova M., Imreh S., and Dumanski J.P. The human LARGE gene from 22q12.3-q13.1 is a new, distinct member of the glycosyltransferase gene family. Proc Natl Acad Sci USA 96 (1999) 598-603
23. Grewal P.K., and Hewitt J.E. Glycosylation defects: a new mechanism for muscular dystrophy?. Hum Mol Genet 12 Spec No. 2 (2003) R259-R264
24. Barresi R., and Campbell K.P. Dystroglycan: from biosynthesis to pathogenesis of human disease. J Cell Sci 119 (2006) 199-207
25. Moore S.A., Saito F., Chen J., Michele D.E., Henry M.D., Messing A., et al. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature 418 (2002) 422-425
26. Herbst R., Avetisova E., and Burden S.J. Restoration of synapse formation in Musk mutant mice expressing a Musk/Trk chimeric receptor. Development 129 (2002) 5449-5460
27. Herbst R., and Burden S.J. The juxtamembrane region of MuSK has a critical role in agrin-mediated signaling. Embo J 19 (2000) 67-77
28. Zhu X., Lai C., Thomas S., and Burden S.J. Neuregulin receptors, erbB3 and erbB4, are localized at neuromuscular synapses. Embo J 14 (1995) 5842-5848
29. Koelle G.B., and Friedenwald J.S. A biochemical method for localizing cholinesterase activity. Proc Soc Ex Biol Methods 70 (1949) 617-622
30. Ryder-Cook A.S., Sicinski P., Thomas K., Davies K.E., Worton R.G., Barnard E.A., et al. Localization of the mdx mutation within the mouse dystrophin gene. Embo J 7 (1988) 3017-3021
31. Grady R.M., Teng H., Nichol M.C., Cunningham J.C., Wilkinson R.S., and Sanes J.R. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 90 (1997) 729-738
32. DeChiara T.M., Bowen D.C., Valenzuela D.M., Simmons M.V., Poueymirou W.T., Thomas S., et al. The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell 85 (1996) 501-512
33. Gautam M., Noakes P.G., Mudd J., Nichol M., Chu G.C., Sanes J.R., et al. Failure of postsynaptic specialization to develop at neuromuscular junctions of rapsyn-deficient mice. Nature 377 (1995) 232-236
34. Gautam M., Noakes P.G., Moscoso L., Rupp F., Scheller R.H., Merlie J.P., et al. Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell 85 (1996) 525-535
35. Peters M.F., Kramarcy N.R., Sealock R., and Froehner S.C. β2-Syntrophin: localization at the neuromuscular junction in skeletal muscle. Neuroreport 5 (1994) 1577-1580
36. Noda M., Takahashi H., Tanabe T., Toyosato M., Furutani Y., Hirose T., et al. Primary structure of α-subunit precursor of Torpedo californica acetylcholine receptor deduced from cDNA sequence. Nature 299 (1982) 793-797
37. Kao P.N., Dwork A.J., Kaldany R.R., Silver M.L., Wideman J., Stein S., et al. Identification of the α-subunit half-cystine specifically labeled by an affinity reagent for the acetylcholine receptor binding site. J Biol Chem 259 (1984) 11662-11665
38. Martin P.T. Glycobiology of the neuromuscular junction. J Neurocytol 32 (2003) 915-929
39. Blanchard D., Capon C., Leroy Y., Cartron J.P., and Fournet B. Comparative study of glycophorin A derived O-glycans from human Cad, Sd(a+) and Sd(a-) erythrocytes. Biochem J 232 (1985) 813-818
40. Donald A.S., Yates A.D., Soh C.P., Morgan W.T., and Watkins W.M. A blood group Sda-active pentasaccharide isolated from Tamm-Horsfall urinary glycoprotein. Biochem Biophys Res Commun 115 (1983) 625-631
41. Piller V., Piller F., and Cartron J.P. Comparison of the carbohydrate-binding specificities of seven N-acetyl-d-galactosamine-recognizing lectins. Eur J Biochem 191 (1990) 461-466
42. Lee Y., Kameya S., Cox G.A., Hsu J., Hicks W., Maddatu T.P., et al. Ocular abnormalities in Large(myd) and Large(vls) mice, spontaneous models for muscle, eye, and brain diseases. Mol Cell Neurosci 30 (2005) 160-172
43. Levedakou E.N., Chen X.J., Soliven B., and Popko B. Disruption of the mouse Large gene in the enr and myd mutants results in nerve, muscle, and neuromuscular junction defects. Mol Cell Neurosci 28 (2005) 757-769
44. Taniguchi M., Kurahashi H., Noguchi S., Fukudome T., Okinaga T., Tsukahara T., et al. Aberrant neuromuscular junctions and delayed terminal muscle fiber maturation in α-dystroglycanopathies. Hum Mol Genet 15 (2006) 1279-1289
45. Stalberg E., and Falck B. The role of electromyography in neurology. Electroencephalogr clin neurophysiol 103 (1997) 579-598
46. Rafuse V.F., Polo-Parada L., and Landmesser L.T. Structural and functional alterations of neuromuscular junctions in NCAM-deficient mice. J Neurosci 20 (2000) 6529-6539
47. Slater C.R. Structural factors influencing the efficacy of neuromuscular transmission. Ann NY Acad Sci 1132 (2008) 1-12
48. Kummer T.T., Misgeld T., Lichtman J.W., and Sanes J.R. Nerve-independent formation of a topologically complex postsynaptic apparatus. J Cell Biol 164 (2004) 1077-1087
49. Sugiyama J.E., Glass D.J., Yancopoulos G.D., and Hall Z.W. Laminin-induced acetylcholine receptor clustering: an alternative pathway. J Cell Biol 139 (1997) 181-191
50. Lin W., Dominguez B., Yang J., Aryal P., Brandon E.P., Gage F.H., et al. Neurotransmitter acetylcholine negatively regulates neuromuscular synapse formation by a Cdk5-dependent mechanism. Neuron 46 (2005) 569-579
51. Misgeld T., Kummer T.T., Lichtman J.W., and Sanes J.R. Agrin promotes synaptic differentiation by counteracting an inhibitory effect of neurotransmitter. Proc Natl Acad Sci USA 102 (2005) 11088-11093
52. Saito F., Moore S.A., Barresi R., Henry M.D., Messing A., Ross-Barta S.E., et al. Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization. Neuron 38 (2003) 747-758
53. Reddy L.V., Koirala S., Sugiura Y., Herrera A.A., and Ko C.P. Glial cells maintain synaptic structure and function and promote development of the neuromuscular junction in vivo. Neuron 40 (2003) 563-580
54. Wolpowitz D., Mason T.B., Dietrich P., Mendelsohn M., Talmage D.A., and Role L.W. Cysteine-rich domain isoforms of the neuregulin-1 gene are required for maintenance of peripheral synapses. Neuron 25 (2000) 79-91
55. Mishina M., Takai T., Imoto K., Noda M., Takahashi T., Numa S., et al. Molecular distinction between fetal and adult forms of muscle acetylcholine receptor. Nature 321 (1986) 406-411
56. Sine S.M. Identification of equivalent residues in the gamma, delta, and epsilon subunits of the nicotinic receptor that contribute to α-bungarotoxin binding. J Biol Chem 272 (1997) 23521-23527
57. Poulter L., Earnest J.P., Stroud R.M., and Burlingame A.L. Structure, oligosaccharide structures, and posttranslationally modified sites of the nicotinic acetylcholine receptor. Proc Natl Acad Sci USA 86 (1989) 6645-6649
58. Shoji H., Takahashi N., Nomoto H., Ishikawa M., Shimada I., Arata Y., et al. Detailed structural analysis of asparagine-linked oligosaccharides of the nicotinic acetylcholine receptor from Torpedo californica. Eur J Biochem 207 (1992) 631-641
59. Mishina M., Tobimatsu T., Imoto K., Tanaka K., Fujita Y., Fukuda K., Kurasaki M., Takahashi H., Morimoto Y., Hirose T., et al. Location of functional regions of acetylcholine receptor α-subunit by site-directed mutagenesis. Nature 313 (1985) 364-369
60. Sumikawa K., and Gehle V.M. Assembly of mutant subunits of the nicotinic acetylcholine receptor lacking the conserved disulfide loop structure. J Biol Chem 267 (1992) 6286-6290
61. Gehle V.M., and Sumikawa K. Site-directed mutagenesis of the conserved N-glycosylation site on the nicotinic acetylcholine receptor subunits. Brain Res Mol Brain Res 11 (1991) 17-25
62. Barresi R., Michele D.E., Kanagawa M., Harper H.A., Dovico S.A., Satz J.S., et al. LARGE can functionally bypass α-dystroglycan glycosylation defects in distinct congenital muscular dystrophies. Nat Med 10 (2004) 696-703
63. Tollefsen S.E., and Kornfeld R. The B4 lectin from Vicia villosa seeds interacts with N-acetylgalactosamine residues α-linked to serine or threonine residues in cell surface glycoproteins. J Biol Chem 258 (1983) 5172-5176
64. Tollefsen S.E., and Kornfeld R. Isolation and characterization of lectins from Vicia villosa. Two distinct carbohydrate-binding activities are present in seed extracts. J Biol Chem 258 (1983) 5165-5171
65. Puri K.D., Gopalakrishnan B., and Surolia A. Carbohydrate-binding specificity of the Tn-antigen binding lectin from Vicia villosa seeds (VVLB4). FEBS Lett 312 (1992) 208-212
66. Hoyte K., Kang C., and Martin P.T. Definition of pre- and postsynaptic forms of the CT carbohydrate antigen at the neuromuscular junction: ubiquitous expression of the CT antigens and the CT GalNAc transferase in mouse tissues. Brain Res Mol Brain Res 109 (2002) 146-160
67. Sanes J.R., and Cheney J.M. Lectin binding reveals a synapse-specific carbohydrate in skeletal muscle. Nature 300 (1982) 646-647
68. Xia B., Hoyte K., Kammesheidt A., Deerinck T., Ellisman M., and Martin P.T. Overexpression of the CT GalNAc transferase in skeletal muscle alters myofiber growth, neuromuscular structure, and laminin expression. Dev Biol 242 (2002) 58-73
69. Endo T. O-mannosyl glycans in mammals. Biochim Biophys Acta 1473 (1999) 237-246
70. Ibraghimov-Beskrovnaya O., Ervasti J.M., Leveille C.J., Slaughter C.A., Sernett S.W., and Campbell K.P. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355 (1992) 696-702